|
|
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial
Meletios Dimopoulos
,
Judith Trotman
,
Alessandra Tedeschi
,
Jeffrey V Ma
,
David Ma
et al.
Journal articles
hal-01653571v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Real-world results of ibrutinib in relapsed/refractory CLL in France: Early results on a large series of 428 patients
Loic Ysebaert
,
Thérèse Aurran-Schleinitz
,
Caroline Dartigeas
,
Marie-Sarah Dilhuydy
,
Pierre Feugier
et al.
Journal articles
hal-01655976v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families
Anne Laure Renault
,
Noura Mebirouk
,
Eve Cavaciuti
,
Dorothée Le Gal
,
J. Lecarpentier
et al.
Journal articles
hal-01658591v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma
Steven Le Gouill
,
Catherine Thieblemont
,
Lucie Oberic
,
Anne Moreau
,
Krimo Bouabdallah
et al.
Journal articles
hal-02329536v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Aggressive skin cancers in patients who experienced chronic GvHD after allogeneic bone marrow transplantation
A Zampaolo
,
J. Kanold
,
O. Tournilhac
,
F Franck
,
M Bachelerie
et al.
Journal articles
hal-01655888v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia
Yannick Le Bris
,
Stéphanie Struski
,
Romain Guiéze
,
Caroline Rouvellat
,
Nais Prade
et al.
Journal articles
hal-01677945v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Jerome Stirnemann
,
Nadia Belmatoug
,
Fabrice Camou
,
Christine Serratrice
,
Roseline Rose
et al.
Journal articles
hal-01653579v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Étude du chimérisme après allogreffe de cellules hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
Valérie Dubois
,
Mehdi Alizadeh
,
Jean Henri Bourhis
,
Pascaline Etancelin
,
Olivier Farchi
et al.
Journal articles
hal-01664161v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Therapeutic Drug Monitoring of Carboplatin in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors: Pharmacokinetic Results of a Phase II Multicenter Study
Sotheara Moeung
,
Christine Chevreau
,
Sophie Broutin
,
Jérome Guitton
,
Bénédicte Lelièvre
et al.
Journal articles
hal-01659726v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Reduced-intensity vs reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted nonHodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
A. Le Bourgeois
,
M. Labopin
,
D. Blaise
,
P. Ceballos
,
S. Vigouroux
et al.
Journal articles
hal-01655965v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effect of Azithromycin on Airflow Decline–Free Survival After Allogeneic Hematopoietic Stem Cell Transplant
Anne Bergeron
,
Sylvie Chevret
,
Angela Granata
,
Patrice Chevallier
,
Laure Vincent
et al.
Journal articles
hal-01655930v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Consolidation anti-CD22 fractionated radioimmunotherapy with 90 Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial
Francoise Kraeber-Bodere
,
Amandine Pallardy
,
Hervé Maisonneuve
,
Loïc Campion
,
Anne Moreau
et al.
Journal articles
hal-02425339v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data
Tatiana Raskovalova
,
Patrick B. Deegan
,
Ruby Yang
,
Elena Pavlova
,
Jérôme Stirnemann
et al.
Journal articles
hal-01655857v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group
Sophie Michallet
,
Arnaud Campidelli
,
Helene Lequeu
,
Marie-Sarah Dilhuydy
,
Olivier Tournilhac
et al.
Journal articles
hal-01653723v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study
Alexandre Morel
,
Josette Brière
,
Laurence Lamant
,
Michael Loschi
,
Corinne Haioun
et al.
Journal articles
hal-01655967v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone
Véronique Leblond
,
Pierre Morel
,
Marie-Sarah Dilhuidy
,
Xavier Leleu
,
Carole Soussain
et al.
Journal articles
hal-01655961v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
SnapShot: Chronic Lymphocytic Leukemia
Elisa ten Hacken
,
Romain Guièze
,
Catherine J. Wu
Journal articles
hal-01659737v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD
Gérard Socié
,
Stéphane Vigouroux
,
Ibrahim Yakoub-Agha
,
Jacques-Olivier Bay
,
Sabine Furst
et al.
Journal articles
hal-01655868v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Santé publique et volonté politique : convergences et divergences
Stéphane Vignot
,
Gilles L’allemain
,
Jacques-Olivier Bay
Journal articles
hal-01655997v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Retour vers le futur
Stéphane Vignot
,
Gilles L’allemain
,
Jacques-Olivier Bay
Journal articles
hal-01655998v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party
B Bento
,
B Boumendil
,
F Finel
,
S. Le Gouill
,
S Amorim
et al.
Journal articles
hal-01655912v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study
Pernelle Noize
,
Angela Grelaud
,
Jacques-Olivier Bay
,
Christine Chevreau
,
Marine Gross-Goupil
et al.
Journal articles
hal-01659732v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
Laurent Gilardin
,
Sandrine Delignat
,
Ivan Peyron
,
Mathieu Ing
,
Yu-Chun Lone
et al.
Journal articles
hal-02466291v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF)
Loïc Lebellec
,
Bruno Chauffert
,
Jean-Yves Blay
,
Axel Le Cesne
,
Christine Chevreau
et al.
Journal articles
hal-01655981v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pomalidomide dans les myélomes multiples
Aurore Dougé
,
Richard Lemal
,
Carine Chaleteix
Journal articles
hal-01655995v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia
Gregory Lazarian
,
Romain Guieze
,
Catherine J. Wu
Journal articles
hal-01655956v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bone marrow hematons: An access point to the human hematopoietic niche
Alexandre Janel
,
Juliette Berger
,
Céline Bourgne
,
Richard Lemal
,
Nathalie Boiret-Dupré
et al.
Journal articles
hal-01655946v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study
Godelieve Meunier
,
Loic Ysebaert
,
Phi Linh Nguyen-Thi
,
Stéphane Leprêtre
,
Anne Quinquenel
et al.
Journal articles
hal-01672884v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia
Caroline Algrin
,
Jean-Louis Golmard
,
Mauricette Michallet
,
Oumedaly Reman
,
Anne Huynh
et al.
Journal articles
hal-01653556v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Type 3 Gaucher disease, diagnostic in adulthood
Charles Detollenaere
,
Monia Benghergbia
,
Anaïs Brassier
,
Thierry Billette de Villemeur
,
Daniel Amsallem
et al.
Journal articles
hal-01653712v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|